BRYAN HOFHEINS: Open Payments
NPI 1326147034 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$714 in 39 payments from 11 companies in 2025. Trend: 2023 $553 · 2024 $1,178 · 2025 $714
Food & beverage: $714
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $290 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $141 |
| Janssen Biotech, Inc. | 4 | $83 |
| ABBVIE INC. | 3 | $67 |
| Organon LLC | 2 | $31 |
| Smith+Nephew, Inc. | 1 | $21 |
| Almirall LLC | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| Botanix SB Inc | 1 | $16 |
| GENZYME CORPORATION | 1 | $14 |
Products named: COSENTYX, ILUMYA, TREMFYA, SKYRIZI, Rhapsido, BLU-U, GRAFIX PL, Seysara.
Industry payments across UT — which companies pay providers there.
